REVOLUTION MEDICINES INC
RVMDNASDAQ🏆 #330 by market capEarnings Nov 4 · PostUS Equity
$188.72▲ $2.50 (+1.34%)
🌙 After hours$188.00▼ 0.38%Regular close · extended-hours price shownTrack RVMD
Get earnings, price moves & breaking news on Telegram
24h▲ 1.3%
7d▲ 0.6%
14d▼ 0.3%
30d▼ 7.7%
ytd▲ 136.9%
1y▲ 225.2%
🏦Market Cap
$40.45B
Mid Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
3495.5x
Expensive
Otter Score
—
Insufficient data
REVOLUTION MEDICINES INC
RVMDAnalyst Ratings
Price
$188.72
Total
25
Raised
0
Lowered
0
Avg PT
$253.47
H / L
$320 / $179
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
TD Cowen | Reiterated | Buy | 2026-10-21 | — | — |
Truist Securities | Reiterated | Buy | 2026-10-19 | — | — |
Needham | Reiterated | Buy | 2026-10-15 | $275.00 | +45.70% |
RBC Capital | Reiterated | Outperform | 2026-10-14 | $260.00 | +37.80% |
B of A Securities | Reiterated | Buy | 2026-09-21 | — | — |
Stifel | Reiterated | Buy | 2026-09-09 | — | — |
Guggenheim | Reiterated | Buy | 2026-08-28 | $275.00 | +45.70% |
UBS | Reiterated | Buy | 2026-08-28 | $265.00 | +40.40% |
Evercore ISI Group | Reiterated | Outperform | 2026-08-27 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2026-08-27 | — | — |
Wedbush | Reiterated | Outperform | 2026-08-27 | $201.00 | +6.50% |
Oppenheimer | Reiterated | Outperform | 2026-08-27 | $260.00 | +37.80% |
Bernstein | Reiterated | Market Perform | 2026-08-21 | $179.00 | −5.20% |
Mizuho | Reiterated | Outperform | 2026-07-06 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-05-07 | $75.00 | −60.30% |
Leerink Partners | Reiterated | Outperform | 2026-04-22 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-04-14 | $144.00 | −23.70% |
JP Morgan | Reiterated | Overweight | 2026-02-02 | — | — |
Raymond James | Reiterated | Strong Buy | 2025-10-17 | $248.00 | +31.40% |
Goldman Sachs | Reiterated | Buy | 2025-09-12 | $267.00 | +41.50% |
Barclays | Reiterated | Overweight | 2024-09-27 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2024-03-08 | $255.00 | +35.10% |
SVB Leerink | Reiterated | Outperform | 2022-08-10 | — | — |
Guggenheim Securities | Reiterated | Buy | 2020-03-09 | — | — |
Cowen & Co. | Reiterated | Outperform | 2020-03-09 | — | — |
Institution
TD Cowen
Reiterated · Buy · 2026-10-21
—
—
Truist Securities
Reiterated · Buy · 2026-10-19
—
—
Needham
Reiterated · Buy · 2026-10-15
$275.00
+45.70%
RBC Capital
Reiterated · Outperform · 2026-10-14
$260.00
+37.80%
B of A Securities
Reiterated · Buy · 2026-09-21
—
—
Stifel
Reiterated · Buy · 2026-09-09
—
—
Guggenheim
Reiterated · Buy · 2026-08-28
$275.00
+45.70%
UBS
Reiterated · Buy · 2026-08-28
$265.00
+40.40%
Evercore ISI Group
Reiterated · Outperform · 2026-08-27
—
—
HC Wainwright & Co.
Reiterated · Buy · 2026-08-27
—
—
Wedbush
Reiterated · Outperform · 2026-08-27
$201.00
+6.50%
Oppenheimer
Reiterated · Outperform · 2026-08-27
$260.00
+37.80%
Bernstein
Reiterated · Market Perform · 2026-08-21
$179.00
−5.20%
Mizuho
Reiterated · Outperform · 2026-07-06
—
—
Piper Sandler
Reiterated · Overweight · 2026-05-07
$75.00
−60.30%
Leerink Partners
Reiterated · Outperform · 2026-04-22
—
—
Wells Fargo
Reiterated · Overweight · 2026-04-14
$144.00
−23.70%
JP Morgan
Reiterated · Overweight · 2026-02-02
—
—
Raymond James
Reiterated · Strong Buy · 2025-10-17
$248.00
+31.40%
Goldman Sachs
Reiterated · Buy · 2025-09-12
$267.00
+41.50%
Barclays
Reiterated · Overweight · 2024-09-27
—
—
Morgan Stanley
Reiterated · Equal Weight · 2024-03-08
$255.00
+35.10%
SVB Leerink
Reiterated · Outperform · 2022-08-10
—
—
Guggenheim Securities
Reiterated · Buy · 2020-03-09
—
—
Cowen & Co.
Reiterated · Outperform · 2020-03-09
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space